AAM Sees Boon From Biden Order And CMS Biosimilar Action

US Generics And Biosimilars Industry Association Welcomes Latest Developments

 
• By David Wallace
  
Joe Biden Black Background
Biden’s executive order is aimed at lowering prescription drug costs • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Policy & Regulation

More from Generics Bulletin